Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease

Parkinson's Disease - Egypt
doi 10.1155/2012/943159
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Metoclopramide and Pimozide in Parkinson's Disease and Levodopa-Induced Dyskinesias.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1975English

Clinical Features and Electrocardiogram Parameters in Parkinson’s Disease

Neurology International
Neurology
2017English

Facing the Unique Challenges of Dyskinesias in Parkinson’s Disease

Future Neurology
Neurology
2012English

Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology

Frontiers in Neurology
Neurology
2014English

Parkinson's Disease: General Features, Effects of Levodopa Treatment and Future Directions

Frontiers in Neuroanatomy
AnatomyNeuroscienceCellularMolecular Neuroscience
2010English

Gut Bacterial Tyrosine Decarboxylases Restrict Levels of Levodopa in the Treatment of Parkinson’s Disease

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

The Effects of Levodopa on Gait in Parkinson’s Disease

New Zealand Journal of Physiotherapy
Physical TherapySports TherapyRehabilitation
2017English

Management of Levodopa for Residents With Parkinson’s Disease

Nursing older people
Gerontology
2016English

Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates

Frontiers in Neurology
Neurology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy